Abstract
Purpose
The purpose of this study is to investigate the value of a modified neoadjuvant short-course radiation therapy (SCRT) in uT3 rectal carcinoma, which, despite local R0 resectability, carries a greater risk of local recurrence than less invasive carcinomas.
Methods
Sixty-three patients with uT3 rectal carcinoma ≤10 cm above the anal verge received a modified 8 × 3 Gy pre-operative SCRT. Radiation-associated and peri-operative complications were recorded, and the patients were followed up for long-term oncological outcome and morbidity.
Results
In the study group, there were no severe adverse radiation-associated effects; the rate of peri-operative morbidity was 54.0% and that of in-hospital mortality is 4.8%. The probability (Kaplan–Meier estimate) of local recurrence was 3.9% with a probability of metachronic distant metastases of 26.8% (5-year rates). We found the probability of 5-year disease-free survival to be 70.5% and that of 5-year overall survival, 59.5%. Long-term complications were reported for 31.7% of patients.
Conclusions
Compared to the literature-modified 8 × 3 Gy neoadjuvant SCRT and surgery in uT3, rectal carcinoma was associated with low local recurrence but frequent peri-operative complications. The decisive prognostic factor, distant metastasis, was unaffected. Difficulties included overestimation of tumour invasion depth by endosonography. Possible clinical consequences of the results are discussed.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-009-0823-y/MediaObjects/384_2009_823_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-009-0823-y/MediaObjects/384_2009_823_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-009-0823-y/MediaObjects/384_2009_823_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-009-0823-y/MediaObjects/384_2009_823_Fig4_HTML.gif)
Similar content being viewed by others
References
Heald B (2006) Better surgery and better selection for adjuvants—still the key to improving outcomes in rectal cancer. Acta Chir Iugosl 53:35–37
Hermanek P, Heald RJ (2004) Pre-operative radiotherapy for rectal carcinoma? Has the case really been made for short course pre-operative radiotherapy if surgical standards for rectal carcinoma are optimal? Colorectal Dis 6:288–289
Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, The German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740
Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980–987
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Påhlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646
Brooks S, Glynne-Jones R, Novell R, Harrison M, Brown K, Makris A (2006) Short course continuous, hyperfractionated, accelerated radiation therapy (CHART) as preoperative treatment for rectal cancer. Acta Oncol 45:1079–1085
Widder J, Herbst F, Dobrowsky W, Schmid R, Pokrajac B, Jech B et al (2005) Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II). Br J Cancer 92:1209–1214
Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 358:1291–1304
Lippert H, Gastinger I (2006) Versorgung von Patienten mit Rektumkarzinomen in Deutschland [Medical Care of Patients with Rectal Carcinoma in Germany]. Dtsch Arztebl 103:A2704–A2709
Ptok H, Marusch F, Kuhn R, Gastinger I, Lippert H (2007) Influence of hospital volume on the frequency of abdominoperineal resection and long-term oncological outcomes in low rectal cancer. Eur J Surg Oncol 33:854–861
Ulrich A, Schwerdt J, Z’graggen K, Kienle P, Weitz J, Büchler MW (2007) Acceptance of neoadjuvant short-term radiotherapy: a survey under surgeons and radiotherapists. Langenbeck’s Arch Surg 392:525–533
Kornmann M, Henne-Bruns D (2008) Qualität der Datengrundlage zu Evidence-based-Medicine - Rektumkarzinom und präoperative 5 × 5 Bestrahlung [Quality for the data basis of evidence-based medicine: rectal cancer and preoperative 5 × 5 irradiation]. Zentralbl Chir 133:20–24
Folkesson J, Birgisson H, Påhlman L, Cedermark B, Glimelius B, Gunnarsson U (2005) Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23:5644–5650
Pieterse AH, Stiggelbout AM, Baas-Thijssen MC, van de Velde CJ, Marijnen CA (2007) Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients’ and oncologists’ preferences. Br J Cancer 97:717–724
Siegel R, Dresel S, Koswig S, Gebauer B, Hünerbein M, Schneider W, Schlag PM (2008) Response to preoperative short-course radiotherapy in locally advanced rectal cancer: value of f-fluorodeoxyglucose positron emission tomography. Onkologie 31:166–172
Ulrich A, Weitz J, Friess H, Büchler M (2006) Fiktion und Fakten bei der multimodalen Therapie des Rektumkarzinoms [Fiction and facts about multi-modal therapy in rectal cancer]. Zentralbl Chir 131:134–139
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M, for the Polish Colorectal Cancer Group (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–1223
Marijnen CA, Kapiteijn E, van de Velde CJ, Martijn H, Steup WH, Wiggers T, Kranenbarg EK, Leer JW, the Cooperative Investigators of the Dutch Colorectal Cancer Group (2002) Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectum excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 20:817–825
van der Vaart MG, van der Zwet WC, Arends JW, Eeftinck Schattenkerk M, Eddes EH (2006) Rectal carcinoma treated with short-term preoperative radiotherapy followed by abdominoperineal resection. Significantly more presacral abscesses with absence of local recurrence. Dig Surg 23:173–177
Bujko K, Nowacki MP, Kepka L, Oledzki J, Bebenek M, Kryj M, Polish Colorectal Study Group (2005) Postoperative complications in patients irradiated pre-operatively for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs chemoradiation. Colorectal Dis 7:410–416
Valenti V, Hernandez-Lizoain JL, Baixauli J, Pastor C, Aristu J, Diaz-Gonzalez J, Beunza JJ, Alvarez-Cienfuegos JA (2007) Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy. Ann Surg Oncol 14:1744–1751
Birgisson H, Påhlman L, Gunnarsson U, Glimelius B (2007) Late adverse effects of radiation therapy for rectal cancer—a systematic overview. Acta Oncol 46:504–516
Marijnen CA, van de Velde CJ, Putter H, van den Brink M, Maas CP, Martijn Rutten HJ, Wiggers T, Kranenbarg EK, Leer JW, Stiggelbout AM (2005) Impact of short term preoperative radiotherapy on health related quality of live and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 23:1847–1858
Peeters KCMJ, Marijnen CAM, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlmann L, Glimelius B, Leer JW, van de Velde CJH, for the Dutch Colorectal Cancer Group (2007) The TME Trial after a median follow up of 6 years. Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693–701
Pollack J, Holm T, Cedermark B, Altman D, Holmström B, Glimelius B, Mellgren A (2006) Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 93:1519–1525
Prabhudesai AG, Cornes P, Glees JP, Kumar D (2005) Long-term morbidity following short-course, pre-operative radiotherapy and total mesorectal excision for rectal cancer. Surgeon 3:347–351
Peeters KCMJ, van de Velde CJH, Leer JWH, Martijn H, Junggeburt JMC, Klein E, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CAM (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch Colorectal Cancer Group Study. J Clin Oncol 23:6199–6206
Birgisson H, Påhlman L, Gunnarsson U, Glimelius B (2005) Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23:6126–6131
Pietrzak L, Bujko K, Nowacki MP, Kepka L, Oledzki J, Rutkowski A, Szmeja J, Kladny J, Dymecki D, Wieczorek A, Pawlak M, Lesniak T, Kowalska T, Richter P, Polish Colorectal Study Group (2007) Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiother Oncol 84:217–225
Glimelius B (2006) Rectal cancer irradiation. Long course, short course or something else? Acta Oncol 45:1013–1017
Jacques AE, Rockall AG, Alijani M, Hughes J, Babar S, Aleong JA, Cottrill C, Dorudi S, Reznek RH (2007) MRI demonstration of the effect of neoadjuvant radiotherapy on rectal carcinoma. Acta Oncol 18:1–7
Bakx R, Emous M, Legemate DA, Zoetmulder FA, van Tienhoven G, Bemelman WA, van Lanschot JJ (2006) Harm and benefits of short-term pre-operative radiotherapy in patients with resectable rectal carcinomas. Eur J Surg Oncol 5:520–526
Wolberink SV, Beets-Tan RG, Nagtegaal ID, Wiggers T (2006) Preoperative assessment of the circumferential margin in rectal cancer is more informative in treatment planning than the T stage. Tech Coloproctology 10:171–176
Nagtegaal ID, Marijnen CAM, Nagtegaal ID, Kranenbarg EK, van de Velde CJH, Krieken HJM (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 26:350–357
Branagan G, Chave H, Fuller C, Mc Gee S, Finnes D (2004) Can magnetic resonance imaging predict circumferential margins and TNM stage in rectal cancer. Dis Colon Rectum 8:1317–1322
Peschaud F, Cuenod CA, Benoist S, Julié C, Beauchet A, Siauve N, Taieb-Kasbi F, Penna C, Nordlinger B (2005) Accuracy of magnetic resonance imaging in rectal cancer depends on location of the tumor. Dis Colon Rectum 48:1603–1609
Daniels IR, Fisher SE, Heald RJ, Moran BJ (2007) Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence. Colorectal Dis 9:290–301
Junginger T, Hermanek P, Oberholzer K, Schmidberger H (2006) Rektumkarzinom: Behandeln wir zu häufig neoadjuvant? Vorschläge zu einer selektiveren, MRT-basierten Indikation. [Rectal carcinoma: is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication]. Zentralbl Chir 131:275–284
Coucke PA, Notter M, Matter M, Fasolini F, Calmes JM, Schlumpf R, Schwegler N, Stamm B, Phuoc Do H, Bouzourene H (2006) Effect of timing of surgery on survival after preoperative hyperfractionated accelerated radiotherapy (HART) for locally advanced rectal cancer (LARC): is it a matter of days? Acta Oncol 45:1086–1093
Fowler JF (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679–694
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kube, R., Ptok, H., Jacob, D. et al. Modified neoadjuvant short-course radiation therapy in uT3 rectal carcinoma: low local recurrence rate with unchanged overall survival and frequent morbidity. Int J Colorectal Dis 25, 109–117 (2010). https://doi.org/10.1007/s00384-009-0823-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-009-0823-y